Physician profile
Erol Veznedaroglu
NPI 1356368492
$10,698.28
in general payments reported to CMS, 2019-2025
17 companies · $3,001 in 2025
The $3,001 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,871 · 2020: $1,105 · 2021: $515 · 2023: $39.08 · 2024: $167 · 2025: $3,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,730 · Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,729.93 |
| Food and Beverage | $477.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,463.08 | 2019 | |
| Longeviti Neuro Solutions INC | $2,831.86 | 2025 | Clearfit |
| Canon Medical Systems USA, INC. | $1,424.40 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $167.05 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $165.61 | 2021 | |
| Philips North America LLC | $145.04 | 2025 | Azurion 5 M12 |
| Mizuho America, INC. | $123.19 | 2021 | |
| Medtronic, INC. | $114.34 | 2021 | |
| Carl Zeiss Meditec, INC. | $60.67 | 2021 | |
| Osteomed LLC | $57.73 | 2019 | |
| Baxter Healthcare | $27.87 | 2021 | |
| Abbvie INC. | $26.99 | 2023 | Duopa, Ubrelvy |
| Microtransponder, INC. | $24.22 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $22.93 | 2021 | |
| Portola Pharmaceuticals, LLC | $20.04 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $12.09 | 2023 | Anastoclip Gc 8cm (Medium) |
| Integra Lifesciences Corporation | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erol Veznedaroglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.